FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002633980> ?p ?o ?g. }

• W2002633980 abstract "In late 2002, the health authorities of Mozambique implemented sulphadoxine-pyrimethamine (SP)/amodiaquine (AQ) as first-line treatment against uncomplicated falciparum malaria. In 2004, this has been altered to SP/artesunate in line with WHO recommendations of using Artemisinin Combination Therapies (ACTs), despite the fact that all the neighbouring countries have abandoned SP-drug combinations due to high levels of SP drug resistance. In the study area, one year prior to the change to SP/AQ, SP alone was used to treat uncomplicated malaria cases. The study described here investigated the immediate impact of the change to SP on the frequency of SP and CQ resistance-related haplotypes in the Plasmodium falciparum genes Pfdhfr, Pfdhps and Pfcrt before and a year after the introduction of SP. Samples were collected during two cross sectional surveys in early 2002 and 2003 involving 796 and 692 children one year or older and adults randomly selected living in Maciana, an area located in Manhiça district, Southern Mozambique. Out of these, 171 and 173 P. falciparum positive samples were randomly selected to measure the frequency of resistance- related haplotypes in Pfdhfr, Pfdhps and Pfcrt based on results obtained by nested PCR followed by sequence-specific oligonucleotide probe (SSOP)-ELISA. The frequency of the SP-resistance associated Pfdhps double mutant (SGEAA) haplotype increased significantly from 14% to 35% (P < 0.001), while the triple mutant Pfdhfr haplotype (CIRNI) remained high and only changed marginally from 46% to 53% (P = 0.405) after one year with SP as first-line treatment in the study area. Conversely, the combined Pfdhfr/Pfdhps quintuple mutant haplotype increased from 8% to 26% (P = 0.005). The frequency of the chloroquine resistance associated Pfcrt-CVIET haplotype was above 90% in both years. These retrospective findings add to the general concern on the lifespan of the combination of SP/artesunate in Mozambique. The high frequency of quintuple Pfdhfr/Pfdhps haplotypes found here as early as 2002 most likely cause ideal conditions for the development of artesunate tolerance in the P. falciparum populations and may even endanger the sensitivity to the second-line drug, Coartem®." @default.
• W2002633980 created "2016-06-24" @default.
• W2002633980 creator A5010475657 @default.
• W2002633980 creator A5028717171 @default.
• W2002633980 creator A5064952511 @default.
• W2002633980 creator A5067433992 @default.
• W2002633980 creator A5076731045 @default.
• W2002633980 creator A5085522877 @default.
• W2002633980 creator A5041071676 @default.
• W2002633980 date "2008-07-01" @default.
• W2002633980 modified "2023-10-16" @default.
• W2002633980 title "Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique" @default.
• W2002633980 cites W1881167978 @default.
• W2002633980 cites W1950804392 @default.
• W2002633980 cites W1989290058 @default.
• W2002633980 cites W2015380911 @default.
• W2002633980 cites W2057878444 @default.
• W2002633980 cites W2063969257 @default.
• W2002633980 cites W2090155474 @default.
• W2002633980 cites W2099198335 @default.
• W2002633980 cites W2101833647 @default.
• W2002633980 cites W2108075232 @default.
• W2002633980 cites W2109191053 @default.
• W2002633980 cites W2126901899 @default.
• W2002633980 cites W2136464551 @default.
• W2002633980 cites W2142611140 @default.
• W2002633980 cites W2142999550 @default.
• W2002633980 cites W2145633183 @default.
• W2002633980 cites W2158232847 @default.
• W2002633980 cites W2158987255 @default.
• W2002633980 cites W2164187904 @default.
• W2002633980 cites W2168521097 @default.
• W2002633980 doi "https://doi.org/10.1186/1475-2875-7-115" @default.
• W2002633980 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2481262" @default.
• W2002633980 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18590577" @default.
• W2002633980 hasPublicationYear "2008" @default.
• W2002633980 type Work @default.
• W2002633980 sameAs 2002633980 @default.
• W2002633980 citedByCount "29" @default.
• W2002633980 countsByYear W20026339802012 @default.
• W2002633980 countsByYear W20026339802013 @default.
• W2002633980 countsByYear W20026339802014 @default.
• W2002633980 countsByYear W20026339802016 @default.
• W2002633980 countsByYear W20026339802017 @default.
• W2002633980 countsByYear W20026339802018 @default.
• W2002633980 countsByYear W20026339802021 @default.
• W2002633980 crossrefType "journal-article" @default.
• W2002633980 hasAuthorship W2002633980A5010475657 @default.
• W2002633980 hasAuthorship W2002633980A5028717171 @default.
• W2002633980 hasAuthorship W2002633980A5041071676 @default.
• W2002633980 hasAuthorship W2002633980A5064952511 @default.
• W2002633980 hasAuthorship W2002633980A5067433992 @default.
• W2002633980 hasAuthorship W2002633980A5076731045 @default.
• W2002633980 hasAuthorship W2002633980A5085522877 @default.
• W2002633980 hasBestOaLocation W20026339801 @default.
• W2002633980 hasConcept C104317684 @default.
• W2002633980 hasConcept C114851261 @default.
• W2002633980 hasConcept C135763542 @default.
• W2002633980 hasConcept C159047783 @default.
• W2002633980 hasConcept C197754878 @default.
• W2002633980 hasConcept C203014093 @default.
• W2002633980 hasConcept C2776120307 @default.
• W2002633980 hasConcept C2776992834 @default.
• W2002633980 hasConcept C2777035104 @default.
• W2002633980 hasConcept C2777234095 @default.
• W2002633980 hasConcept C2777425658 @default.
• W2002633980 hasConcept C2778048844 @default.
• W2002633980 hasConcept C2778059366 @default.
• W2002633980 hasConcept C2778301690 @default.
• W2002633980 hasConcept C2778371730 @default.
• W2002633980 hasConcept C2780441369 @default.
• W2002633980 hasConcept C2780866276 @default.
• W2002633980 hasConcept C54355233 @default.
• W2002633980 hasConcept C71924100 @default.
• W2002633980 hasConcept C86803240 @default.
• W2002633980 hasConceptScore W2002633980C104317684 @default.
• W2002633980 hasConceptScore W2002633980C114851261 @default.
• W2002633980 hasConceptScore W2002633980C135763542 @default.
• W2002633980 hasConceptScore W2002633980C159047783 @default.
• W2002633980 hasConceptScore W2002633980C197754878 @default.
• W2002633980 hasConceptScore W2002633980C203014093 @default.
• W2002633980 hasConceptScore W2002633980C2776120307 @default.
• W2002633980 hasConceptScore W2002633980C2776992834 @default.
• W2002633980 hasConceptScore W2002633980C2777035104 @default.
• W2002633980 hasConceptScore W2002633980C2777234095 @default.
• W2002633980 hasConceptScore W2002633980C2777425658 @default.
• W2002633980 hasConceptScore W2002633980C2778048844 @default.
• W2002633980 hasConceptScore W2002633980C2778059366 @default.
• W2002633980 hasConceptScore W2002633980C2778301690 @default.
• W2002633980 hasConceptScore W2002633980C2778371730 @default.
• W2002633980 hasConceptScore W2002633980C2780441369 @default.
• W2002633980 hasConceptScore W2002633980C2780866276 @default.
• W2002633980 hasConceptScore W2002633980C54355233 @default.
• W2002633980 hasConceptScore W2002633980C71924100 @default.
• W2002633980 hasConceptScore W2002633980C86803240 @default.
• W2002633980 hasIssue "1" @default.
• W2002633980 hasLocation W20026339801 @default.
• W2002633980 hasLocation W20026339802 @default.
• W2002633980 hasLocation W20026339803 @default.
• W2002633980 hasLocation W20026339804 @default.

• next